查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1548180

全球癌症組織診斷市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Cancer Tissue Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

全球癌症組織診斷市場需求預計將從 2023 年的 192.8 億美元達到近 298.8 億美元的市場規模，2024-2032 年研究期間複合年成長率為 4.99%。

癌症組織診斷涉及分析組織樣本以識別癌細胞並確定其特徵，這有助於癌症診斷、預後和治療計劃。該過程包括組織病理學、免疫組織化學和分子診斷等多種技術。通常透過活體組織切片獲得的組織樣本被檢查以檢測癌症的存在、類型和階段。這些診斷測試可幫助臨床醫生了解癌症的遺傳和分子特徵，從而製定個人化的治療方法。診斷技術的進步和標靶治療的發展提高了癌症診斷的準確性和有效性，在癌症管理中發揮著至關重要的作用。

市場動態

全球癌症發生率不斷上升，以及對早期和準確診斷的日益重視，推動了癌症組織診斷市場的發展。新一代定序和數位病理學等技術進步提高了癌症診斷的準確性和效率，創造了巨大的市場機會。對個人化醫療和標靶治療的日益關注需要詳細的分子和基因分析，從而推動診斷技術的創新。此外，新興市場中癌症篩檢計畫的日益普及和醫療保健基礎設施的擴大也促進了癌症組織診斷市場的成長。人工智慧和機器學習在診斷過程中的整合進一步增強了能力和效率，提供了更多機會。然而，高成本和複雜的監管要求可能會限制癌症組織診斷市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球癌症組織診斷市場的每個細分市場進行了包容性評估。癌症組織診斷行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

癌症組織診斷市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

  • 原位雜合技術（ISH）檢測試劑盒（螢光原位雜合技術（FISH）試劑盒、顯色原位雜合技術（CISH）試劑盒）
  • 分子診斷檢測試劑盒（聚合酶連鎖反應 (PCR) 試劑盒、新一代定序 (NGS) 試劑盒）
  • 伴隨診斷測試套件（基因測試套件、生物標記測試套件）
  • 免疫組織化學 (IHC) 檢測試劑盒

癌症

  • 乳癌
  • 肺癌
  • 大腸直腸癌
  • 攝護腺癌
  • 卵巢癌
  • 血液癌
  • 肝癌
  • 胰腺癌
  • 皮膚癌（黑色素瘤）
  • 其他

按最終用戶

  • 醫院
  • 專科中心
  • 長期照護中心
  • 診斷中心
  • 學術及研究機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲癌症組織診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。癌症組織診斷市場的主要參與者包括 Abcam Plc、Danaher Corporation、Merck KGaA、Cancer Genetics Inc.、Agilent Technologies Inc.、Enzo Life Sciences Inc.、Abbott、Bio Rad Laboratories Inc.、Thermo Fisher Scientific Inc.、Exact Science 、Biocartis NV、Bio SB、Quidel Corporation、淘大診斷有限公司、F. Hoffmann-La Roche Ltd. 本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：癌症組織診斷 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按癌症分類的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球癌症組織診斷市場分析：按產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 原位雜合技術（ISH）檢測試劑盒（螢光原位雜合技術（FISH）試劑盒、顯色原位雜合技術（CISH）試劑盒）
  • 分子診斷檢測試劑盒（聚合酶連鎖反應 (PCR) 試劑盒、新一代定序 (NGS) 試劑盒）
  • 伴隨診斷測試套件（基因測試套件、生物標記測試套件）
  • 免疫組織化學 (IHC) 檢測試劑盒

第 6 章：全球癌症組織診斷市場分析：按癌症分類

  • 癌症概述
  • 癌症的歷史和預測數據分析
  • 乳癌
  • 肺癌
  • 大腸直腸癌
  • 攝護腺癌
  • 卵巢癌
  • 血液癌
  • 肝癌
  • 胰腺癌
  • 皮膚癌（黑色素瘤）
  • 其他

第 7 章：全球癌症組織診斷市場分析：依最終使用者分類

  • 最終用戶概述
  • 最終用戶的歷史和預測數據分析
  • 醫院
  • 專科中心
  • 長期照護中心
  • 診斷中心
  • 學術及研究機構

第 8 章：全球癌症組織診斷市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：癌症組織診斷公司的競爭格局

  • 癌症組織診斷市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abcam Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cancer Genetics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Agilent Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Enzo Life Sciences Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abbott
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio Rad Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Exact Science
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Biocartis NV
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio SB
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Quidel Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Amoy Diagnostics CO. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115540

The global demand for Cancer Tissue Diagnostics Market is presumed to reach the market size of nearly USD 29.88 Billion by 2032 from USD 19.28 Billion in 2023 with a CAGR of 4.99% under the study period 2024-2032.

Cancer tissue diagnostics involves analyzing tissue samples to identify cancerous cells and determine their characteristics, which aids in cancer diagnosis, prognosis, and treatment planning. This process includes various techniques such as histopathology, immunohistochemistry, and molecular diagnostics. Tissue samples, often obtained through biopsy, are examined to detect cancer presence, type, and stage. These diagnostic tests help clinicians understand the genetic and molecular profile of the cancer, allowing for personalized treatment approaches. Advances in diagnostic technologies and the development of targeted therapies have enhanced the accuracy and effectiveness of cancer diagnostics, playing a crucial role in cancer management.

MARKET DYNAMICS

The cancer tissue diagnostics market is propelled by the increasing incidence of cancer globally, combined with a growing emphasis on early & accurate diagnosis. Technological advancements, such as next-generation sequencing & digital pathology, offer improved accuracy and efficiency in cancer diagnostics, creating significant market opportunities. The rising focus on personalized medicine & targeted therapies necessitates detailed molecular and genetic profiling, driving innovation in diagnostic technologies. Additionally, the growing adoption of cancer screening programs and expanding healthcare infrastructure in emerging markets contribute to the growth of the cancer tissue diagnostics market. The integration of artificial intelligence & machine learning in diagnostic processes further enhances capabilities and efficiency, presenting additional opportunities. However, high costs and complex regulatory requirements may restrain cancer tissue diagnostics market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cancer Tissue Diagnostics. The growth and trends of Cancer Tissue Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cancer Tissue Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits)
  • Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits)
  • Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits)
  • Immunohistochemistry (IHC) Test Kits

By Cancer

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Hematologic Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Skin Cancer (Melanoma)
  • Others

By End-user

  • Hospitals
  • Specialty Centers
  • Long-term Care Centers
  • Diagnostic Centers
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cancer Tissue Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cancer Tissue Diagnostics market include Abcam Plc, Danaher Corporation, Merck KGaA, Cancer Genetics Inc., Agilent Technologies Inc., Enzo Life Sciences Inc, Abbott, Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc., Exact Science, Biocartis NV, Bio SB, Quidel Corporation, Amoy Diagnostics CO. Ltd., F. Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CANCER TISSUE DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Cancer
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits) Historic and Forecast Sales By Regions
  • 5.4. Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits) Historic and Forecast Sales By Regions
  • 5.5. Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits) Historic and Forecast Sales By Regions
  • 5.6. Immunohistochemistry (IHC) Test Kits Historic and Forecast Sales By Regions

6. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY CANCER

  • 6.1. Overview By Cancer
  • 6.2. Historical and Forecast Data Analysis By Cancer
  • 6.3. Breast Cancer Historic and Forecast Sales By Regions
  • 6.4. Lung Cancer Historic and Forecast Sales By Regions
  • 6.5. Colorectal Cancer Historic and Forecast Sales By Regions
  • 6.6. Prostate Cancer Historic and Forecast Sales By Regions
  • 6.7. Ovarian Cancer Historic and Forecast Sales By Regions
  • 6.8. Hematologic Cancer Historic and Forecast Sales By Regions
  • 6.9. Liver Cancer Historic and Forecast Sales By Regions
  • 6.10. Pancreatic Cancer Historic and Forecast Sales By Regions
  • 6.11. Skin Cancer (Melanoma) Historic and Forecast Sales By Regions
  • 6.12. Others Historic and Forecast Sales By Regions

7. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Specialty Centers Historic and Forecast Sales By Regions
  • 7.5. Long-term Care Centers Historic and Forecast Sales By Regions
  • 7.6. Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.7. Academic & Research Institutes Historic and Forecast Sales By Regions

8. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER TISSUE DIAGNOSTICS COMPANIES

  • 9.1. Cancer Tissue Diagnostics Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CANCER TISSUE DIAGNOSTICS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abcam Plc
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Danaher Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merck KGaA
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Cancer Genetics Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Agilent Technologies Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Enzo Life Sciences Inc
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Abbott
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Bio Rad Laboratories Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Exact Science
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Biocartis NV
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Bio SB
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Quidel Corporation
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Amoy Diagnostics CO. Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. F. Hoffmann-La Roche Ltd
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits) Market Sales By Geography (USD MN)
  • Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits) Market Sales By Geography (USD MN)
  • Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits) Market Sales By Geography (USD MN)
  • Immunohistochemistry (IHC) Test Kits Market Sales By Geography (USD MN)
  • Analysis By Cancer (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Colorectal Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Ovarian Cancer Market Sales By Geography (USD MN)
  • Hematologic Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Pancreatic Cancer Market Sales By Geography (USD MN)
  • Skin Cancer (Melanoma) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Centers Market Sales By Geography (USD MN)
  • Long-term Care Centers Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Cancer Tissue Diagnostics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cancer Tissue Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Tissue Diagnostics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Cancer
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits) Market Sales By Geography (USD MN)
  • Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits) Market Sales By Geography (USD MN)
  • Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits) Market Sales By Geography (USD MN)
  • Immunohistochemistry (IHC) Test Kits Market Sales By Geography (USD MN)
  • Global Market Analysis By Cancer (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Colorectal Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Ovarian Cancer Market Sales By Geography (USD MN)
  • Hematologic Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Pancreatic Cancer Market Sales By Geography (USD MN)
  • Skin Cancer (Melanoma) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Centers Market Sales By Geography (USD MN)
  • Long-term Care Centers Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.